 NEW YORK--BUSINESS WIRE--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Immunovant, Inc. fka Health Sciences Acquisitions Corporation NASDAQ: IMVT, HSACU, HSAC, HSACW between October 2, 2019 and February 1, 2021, inclusive the Class Period, of the important April 20, 2021 lead plaintiff deadline. SO WHAT: If you purchased Immunovant securities during the Class Period you may be entitled to compensation without payment of any out of pock 